Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001732369-26-000004

CHIEF EXECUTIVE OFFICER sold 7,015 shares at $16.17 ($113,433)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Seehra Jasbir CHIEF EXECUTIVE OFFICER 2026-02-19 Sale −7,015 $16.17 $113,433 385,708 D: show line 1 in the form
Open-market sales · 7,015 sh · avg $16.17 · $113,433
Loading xslF345X05/form4-02202026_040207.xml…